My lab develops and tests acceptance-based therapies delivered in digital and telehealth platforms, with a focus on addressing health disparities. The most preventable causes of premature death and human suffering are cigarette smoking and obesity. To this end, my research team focuses on designing, developing, and testing AI-based chatbot, smartphone app-delivered, and telephone coach-delivered contextual behavioral interventions for smoking cessation and for weight loss. Research aims include main outcome comparisons, mediators, moderators, intervention engagement, and therapeutic process predictors of outcome. This research is currently supported by multiple NIH R01-level grants. Our lab’s latest grant focuses on testing a smartphone app for helping American Indians and Alaska Natives stop smoking commercial cigarettes.
See links for further information:
https://research.fredhutch.org/habit/en/habit-group-members.html
https://en.wikipedia.org/wiki/Jonathan_Bricker
As a clinical and quantitative psychologist, my work bridges statistical practice and psychological theory to better identify for whom, under what conditions, and why substance-related health disparities are greatest across development. My substantive research seeks to understand how individual differences in stress and developing self-regulation shape substance use and disorder from adolescence through young adulthood, and how these associations explain substance use disparities among sexual and gender minoritized communities. Stemming from this work, my methodological research is centered on improving the analysis and interpretation of nonlinear effects spanning parametric and non-parametric methodologies.
Christina Warner, MD (she/her) is the attending psychiatrist for the Early Psychosis Clinic and Partial Hospitalization Program at Seattle Children’s Hospital. She has clinical expertise in mood disorders, psychosis spectrum disorders, First Episode Psychosis, chronic suicidality, mood dysregulation, neurodiversity, and Dialectical Behavior Therapy.
Dr. Warner is a Washington native and graduate of the Seattle Public School system with a vested interest in expanding access to high quality mental health care in her community.
Dr. Connor Gallik, PhD, is the attending psychologist for the Adolescent Program on the Psychiatry and Behavioral Medicine Unit at Seattle Children’s Hospital and Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at University of Washington.
Prior to joining the staff and faculty at Seattle Children’s/UW, Dr. Gallik completed his graduate education at the University of Connecticut with an emphasis in child and adolescent clinical psychology. He completed his clinical internship at Pacific University’s Psychology and Comprehensive Health Clinic and went on to complete a postdoctoral fellowship in clinical psychology at Seattle Children’s Hospital with an emphasis in DBT and inpatient care.
His research focuses on understanding factors related to the mental health and wellbeing of transgender and gender diverse (TGD) TGD youth and evidence-based practice on inpatient units. Clinically, he is interested in working with children, adolescents, and their families, with a focus on TGD youth. Dr. Gallik also provides training in TGD affirming care for mental health and medical professionals and speaks to community audiences about supporting transgender youth.
I am a trained Behavioral Psychologist with a PhD in Health & Human Performance. The main goal of my work is to reduce substance-related harms and improve quality of life for people experiencing problems related to their substance use. I work closely with community members who use drugs to inform my line of research and address key needs identified. My primary appointment is at the Harm Reduction Research and Treatment (HaRRT) Center within the UW School of Medicine and hold an Affiliate Faculty appointment within the School of Public Health. My aim is to adapt, refine, and disseminate harm reduction programs through digital health interventions to empower individuals and ameliorate substance-related harms.
My scholarship is dedicated to reducing behavioral health disparities in Indigenous, immigrant and refugee communities. I have 13 years of experience and expertise in community-based participatory research (CBPR) science and practice, mixed-methods multi-level research design, cultural adaptation and translation of evidenced based interventions and culture-based practices, survey and measurement development, and dissemination and translation of findings. I am interested in examining culture-centered, land-based healing practices and mechanisms in addressing substance use, sexual health, and climate change impact.
Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. In particular, her work has focused on the intersection of substance use and HIV-related sex and drug risk behaviors from both the consumer and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.
